Ronald J. Lukas
Professor
Neurobiology
Barrow Neurological Institute
United States of America
Biography
Dr. Lukas received his BS degree in physics from the State University of New York College at Cortland and was a National Science Foundation predoctoral trainee at Columbia University in New York City. He went on to earn his PhD in biophysics at the State University of New York Downstate Medical Center, in Brooklyn, New York. He received postdoctoral training in chemical biodynamics at the University of California – Berkeley, and in neurobiology at Stanford University School of Medicine in Palo Alto, California. At Stanford, he was named NINCDS postdoctoral fellow and NIH postdoctoral trainee. Dr. Lukas is an adjunct professor in the Department of Chemistry and Biochemistry and a member of the ASU-BNI Neuroscience Program at Arizona State University. He is also a member of the Neuroscience Graduate Program and a research professor in the Department of Pharmacology at the University of Arizona and its college of medicine. He has been on the grant review committees of a number of organizations, including the National Institutes of Health, the National Science Foundation, and the American Cancer Society.
Research Interest
Nicotinic acetylcholine receptors, Nicotine dependence and tobacco-related diseases
Publications
-
1. Lukas RJ, Changeux JP, le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological reviews. 1999 Jun 1;51(2):397-401.
2. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 2007 Feb 1;190(3):269-319.
3. Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR. Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Molecular pharmacology. 2004 Sep 1;66(3):675-82.
